Chorea Companies
Companies involved in the field of healthcare, biotechnology, or pharmaceuticals, working on treatments or research related to chorea or neurological disorders.
Companies involved in the field of healthcare, biotechnology, or pharmaceuticals, working on treatments or research related to chorea or neurological disorders.
Roche Announced positive Phase 2a trial results for its gene therapy candidate RG6042 for Huntington's disease, paving the way for further development.
UniQure Received FDA Fast Track designation for its gene therapy candidate AMT-130 for Huntington's disease, accelerating the potential pathway to market.
Medtronic Launched its new Percept PC+ DBS system with advanced features for more precise targeting and stimulation control in chorea patients.
Akili Interactive Labs Collaborated with the CHDI Foundation to develop a digital therapeutic game for monitoring motor function in Huntington's disease patients.
List of Chorea Key Companies in the Market
Chorea Market Highlights:
© 2024 Market Research Future ® (Part of WantStats Reasearch And Media Pvt. Ltd.)